Antimalarial chemoprophylaxis for forest goers in southeast Asia: an open-label, individually randomised controlled trial

BACKGROUND: Malaria in the eastern Greater Mekong subregion has declined to historic lows. Countries in the Greater Mekong subregion are accelerating malaria elimination in the context of increasing antimalarial drug resistance. Infections are now increasingly concentrated in remote, forested foci....

Descripción completa

Detalles Bibliográficos
Autores principales: Tripura, Rupam, von Seidlein, Lorenz, Sovannaroth, Siv, Peto, Thomas J, Callery, James J, Sokha, Meas, Ean, Mom, Heng, Chhouen, Conradis-Jansen, Franca, Madmanee, Wanassanan, Peerawaranun, Pimnara, Waithira, Naomi, Khonputsa, Panarasri, Jongdeepaisal, Monnaphat, Pongsoipetch, Kulchada, Chotthanawathit, Paphapisa, Soviet, Ung, Pell, Christopher, Duanguppama, Jureeporn, Rekol, Huy, Tarning, Joel, Imwong, Mallika, Mukaka, Mavuto, White, Nicholas J, Dondorp, Arjen M, Maude, Richard J
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Science ;, The Lancet Pub. Group 2023
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9763125/
https://www.ncbi.nlm.nih.gov/pubmed/36174595
http://dx.doi.org/10.1016/S1473-3099(22)00492-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9763125/
https://www.ncbi.nlm.nih.gov/pubmed/36174595
http://dx.doi.org/10.1016/S1473-3099(22)00492-3

Ejemplares similares